Cheryl Gillett

13.2k citations
145 papers · 11.1k · 2 hit papers · h-index 53

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.5%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

    • Breast Cancer Treatment Studies 28
    • Cancer Genomics and Diagnostics 13
    • HER2/EGFR in Cancer Research 21
    • Cancer-related Molecular Pathways 15
    • Cancer Cells and Metastasis 10

Cheryl Gillett

142 papers receiving 10.8k citations

Cheryl Gillett's Hit Papers

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial 2018 · 701 citations
7010+12+24Years since publication4008001.2k

Peers

Cheryl Gillett
Comparison fields: 5 of 148
  • Cancer Research 2.6k
  • Oncology 4.4k
  • Pathology and Forensic Medicine 1.2k
  • Molecular Biology 4.7k
  • Immunology 1.0k
Replace Carl Morrison with:
Carl Morrison United States
Antonio Cossu Italy
Shikha Bose United States
Hayley B Woffendin United Kingdom
Colin Cooper United Kingdom
Andrew M. Hanby United Kingdom
Pascal Finetti France
Hiran Jayatilake United Kingdom
C. Blake Gilks Canada
Frederic M. Waldman United States
Cheryl Gillett relative to Carl Morrison United States Carl Morrison's profile →
Citations per field
00.5×1.5×
Carl Morrison · 1×
Citations per year

Countries citing papers authored by Cheryl Gillett

Since Specialization
Citations

This map shows the geographic impact of Cheryl Gillett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Gillett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Gillett more than expected).

Fields of papers citing papers by Cheryl Gillett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Gillett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Gillett. The network helps show where Cheryl Gillett may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheryl Gillett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheryl Gillett Line = papers co-authored together Cheryl Gillett links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms
Hit paper breakdown →
19901322
2
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Hit paper breakdown →
2018701
3 2010612
4
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
1994607
5 1997337
6 2010318
7 1989304
8 2006294
9 1996284
10 2019282
11 2007262
12 1998223
13
A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
2000210
14 1993181
15 2011163
16 1995159
17
Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers.
2000139
18 2004135
19 2014129
20 2018127

About Cheryl Gillett

Cheryl Gillett is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Molecular Biology and Immunology and Allergy, having authored 145 papers that have together received 11.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (28 papers), HER2/EGFR in Cancer Research (21 papers), Breast Lesions and Carcinomas (15 papers), Cancer-related Molecular Pathways (15 papers), Cancer Genomics and Diagnostics (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), BRCA gene mutations in cancer (12 papers) and Cancer Cells and Metastasis (10 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (4.4k citations), Pathology and Forensic Medicine (1.2k citations), Molecular Biology (4.7k citations) and Immunology (1.0k citations). Cheryl Gillett has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Diana M. Barnes, D M Barnes, Peter A. Hall, Jorge Sergio Reis-Filho, Rosemary R. Millis, Richard S. Camplejohn, Johnathan A. Watkins, Andrew N.J. Tutt, Naushin H. Waseem and David A. Levison. Their work appears in journals such as The Journal of Pathology, International Journal of Cancer, Breast Cancer Research and Treatment, Breast Cancer Research and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact